Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Streptase 750,000unit powder for solution for injection vials (Aventis Behring Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Topotecan 4mg powder for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Hycamtin 4mg powder for solution for injection vials (GlaxoSmithKline) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Trastuzumab 150mg powder for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Herceptin 150mg powder for solution for injection vials (Roche Products Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Treosulfan 1g powder for solution for injection vials 5 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Treosulfan 1g powder for solution for injection vials (Medac GMBH) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Treosulfan 5g powder for solution for injection vials 5 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Treosulfan 5g powder for solution for injection vials (Medac GMBH) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Hyate:C 700unit powder for solution for injection vials (Ipsen Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Porcine Factor VIII 700unit powder for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Streptokinase 1.5million unit powder for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Streptase 1.5million unit powder for solution for injection vials (Aventis Behring Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Verteporfin 15mg powder for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Visudyne 15mg powder for solution for infusion vials (Neon Healthcare Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Vinblastine 10mg powder for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Velbe 10mg powder for solution for injection vials (Eli Lilly & Co Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Voriconazole 200mg powder for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
VFEND 200mg powder for solution for injection vials (Pfizer Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Terlipressin 1mg powder and solvent for solution for injection vials 5 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Glypressin 1mg powder and solvent for solution for injection vials (Ferring Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Indometacin 1mg powder for solution for injection 1ml vials 3 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Indocid PDA 1mg powder for solution for injection 1ml vials (Merck Sharp & Dohme Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
M-M-R II vaccine powder and solvent for solution for injection 0.5ml vials (Organon Pharma (UK) Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Mengivac A + C powder and solvent for solution for injection vials (Aventis Pasteur MSD Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Palivizumab 100mg powder and solvent for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Synagis 100mg powder and solvent for solution for injection vials (Abbott Laboratories Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Palivizumab 50mg powder and solvent for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Synagis 50mg powder and solvent for solution for injection vials (Abbott Laboratories Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Factor IX 500unit powder and solvent for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Mononine 500unit powder and solvent for solution for injection vials (Aventis Behring Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Factor IX 1,000unit powder and solvent for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Mononine 1,000unit powder and solvent for solution for injection vials (Aventis Behring Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Moroctocog alfa 250unit powder and solvent for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
ReFacto 250unit powder and solvent for solution for injection vials (Wyeth Laboratories) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Moroctocog alfa 500unit powder and solvent for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
ReFacto 500unit powder and solvent for solution for injection vials (Wyeth Laboratories) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
ReFacto 1,000unit powder and solvent for solution for injection vials (Wyeth Laboratories) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Moroctocog alfa 1,000unit powder and solvent for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Interferon beta-1a 30microgram powder and solvent for solution for injection vials 4 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Avonex 30microgram powder and solvent for solution for injection vials (Biogen Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Helixate NexGen 250unit powder and solvent for solution for injection vials (Aventis Behring Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Helixate NexGen 500unit powder and solvent for solution for injection vials (Aventis Behring Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Helixate NexGen 1,000unit powder and solvent for solution for injection vials (Aventis Behring Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Alteplase 10mg powder and solvent for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Actilyse 10mg powder and solvent for solution for injection vials (Boehringer Ingelheim Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Alteplase 20mg powder and solvent for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Actilyse 20mg powder and solvent for solution for injection vials (Boehringer Ingelheim Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Carmustine 100mg powder and solvent for solution for injection vials 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
BiCNU 100mg powder and solvent for solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Rasburicase 1.5mg powder and solvent for solution for injection vials 3 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Alteplase 50mg powder and solvent for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Actilyse 50mg powder and solvent for solution for injection vials (Boehringer Ingelheim Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fasturtec 1.5mg powder and solvent for solution for infusion vials (Sanofi Genzyme) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Rasburicase 7.5mg powder and solvent for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fasturtec 7.5mg powder and solvent for solution for infusion vials (Sanofi Genzyme) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Nonacog alfa 250unit powder and solvent for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fludarabine phosphate 50mg powder for solution for injection vials 5 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fludara 50mg powder for solution for injection vials (Schering Health Care Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
BeneFIX 250unit powder and solvent for solution for injection vials (Baxter Healthcare Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Nonacog alfa 500unit powder and solvent for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
BeneFIX 500unit powder and solvent for solution for injection vials (Baxter Healthcare Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Nonacog alfa 1,000unit powder and solvent for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
BeneFIX 1,000unit powder and solvent for solution for injection vials (Baxter Healthcare Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Caspofungin 50mg powder for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
AlphaNine 500unit powder and solvent for solution for injection vials (Alpha Therapeutic UK Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cancidas 50mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Caspofungin 70mg powder for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cancidas 70mg powder for solution for infusion vials (Organon Pharma (UK) Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Somatorelin 50microgram powder and solvent for solution for injection ampoules 1 ampoule |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
GHRH Ferring 50microgram powder and solvent for solution for injection ampoules (Ferring Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Menotrophin 75unit powder and solvent for solution for injection ampoules 10 ampoule |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Menogon 75unit powder and solvent for solution for injection ampoules (Ferring Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Menotrophin 75unit powder and solvent for solution for injection vials 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Menopur 75unit powder and solvent for solution for injection vials (Ferring Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Factor VIII 1,000unit / von Willebrand factor 2,200unit powder and solvent for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Haemate P 1,000unit powder and solvent for solution for injection vials (Aventis Behring Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Factor VIII 500unit / von Willebrand factor 1,100unit powder and solvent for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Haemate P 500unit powder and solvent for solution for injection vials (Aventis Behring Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Imiglucerase 200unit powder for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cerezyme 200unit powder for solution for injection vials (Genzyme Therapeutics) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Imiglucerase 400unit powder for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cerezyme 400unit powder for concentrate for solution for infusion vials (Sanofi Genzyme) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Glatiramer acetate 20mg powder and solvent for solution for injection vials 28 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Copaxone 20mg powder and solvent for solution for injection vials (Teva UK Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Streptomycin 1g powder for solution for injection vials 10 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Streptomycin 1g powder for solution for injection vials (Celltech Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Somatropin (rbe) 600microgram powder and solvent for solution for injection pre-filled disposable devices 7 pre-filled disposable injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Genotropin MiniQuick 600microgram powder and solvent for solution for injection pre-filled disposable devices (Pfizer Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Somatropin (rbe) 800microgram powder and solvent for solution for injection pre-filled disposable devices 7 pre-filled disposable injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Genotropin MiniQuick 800microgram powder and solvent for solution for injection pre-filled disposable devices (Pfizer Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Somatropin (rbe) 1.2mg powder and solvent for solution for injection pre-filled disposable devices 7 pre-filled disposable injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Genotropin MiniQuick 1.2mg powder and solvent for solution for injection pre-filled disposable devices (Pfizer Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Dacarbazine 600mg powder for solution for injection vials 1 vial |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Dacarbazine 600mg powder for solution for injection vials (Mayne Pharma Plc) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Epoetin beta 60,000unit powder and solvent for solution for injection pre-filled disposable devices 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Somatropin (rbe) 1mg powder and solvent for solution for injection pre-filled disposable devices 7 pre-filled disposable injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
NeoRecormon 60,000unit powder and solvent for solution for injection pre-filled disposable devices (Roche Products Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Genotropin MiniQuick 1mg powder and solvent for solution for injection pre-filled disposable devices (Pfizer Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Somatropin (rbe) 1.4mg powder and solvent for solution for injection pre-filled disposable devices 7 pre-filled disposable injection |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Genotropin MiniQuick 1.4mg powder and solvent for solution for injection pre-filled disposable devices (Pfizer Ltd) |
Has manufactured dose form |
False |
Powder for conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|